First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy
Author: | Saskia Mayer, Marie Prechtl, Pia Liebfried, Ron-Patrick Cadeddu, Fabian Stuhldreier, Matthias KohlORCiDGND, Folker WenzelGND, Björn Stork, Sebastian Wesselborg, Peter Proksch, Ulrich Germing, Rainer Haas, Paul Jäger |
---|---|
URN: | https://urn:nbn:de:bsz:fn1-opus4-56901 |
DOI: | https://doi.org/10.3390/md17090521 |
ISSN: | 1660-3397 |
Parent Title (English): | Marine Drugs |
Document Type: | Article (peer-reviewed) |
Language: | English |
Year of Completion: | 2019 |
Release Date: | 2019/09/06 |
Tag: | Acute myeloid leukemia; Apoptosis; Bioactive natural products; Cytotoxic activity; Drug leads; Marine sponge derived natural products; Peripheral blood mononuclear cells; Polybrominated diphenyl ethers; Primary leukemic cells; Sesquiterpene aminoquinone |
Volume: | 17.2019 |
Issue: | 9 |
Page Number: | 17 |
Open-Access-Status: | Open Access |
Licence (German): | ![]() |